| ［1］Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter［J］. Nature, 2000, 403(6771):776-781.
［2］Wu LJ, Leenders AG, Cooperman S, et al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier［J］. Brain Res, 2004, 1001(12):108-117.
［3］Song N, Wang J, Jiang H, et al. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson’s disease［J］. Free Radic Biol Med, 2010, 48(2):332-341.
［4］Lv Z, Jiang H, Xu H, et al. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease［J］. J Neural Transm, 2011, 118(3):361-369.
［5］Li L, Li YW, Zhao JY, et al. Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia［J］. J Clin Neurosci, 2009, 16(11):1466-1472.
［6］Riddle A, Luo NL, Manese M, et al. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury［J］. J Neurosci, 2006, 26(11): 3045-3055.
［7］Volpe JJ, Kinney HC, Jensen FE, et al. The developing oligodendrocyte: key cellular target in brain injury in the premature infant［J］. Int J Dev Neurosci, 2011, 29(4):423-440.
［8］Asou H, Hamada K, Miyazaki T, et al. CNS myelinogenesis in vitro: time course and pattern of rat oligodendrocyte development［J］. J Neurosci Res, 1995,40(4):519-534.
［9］Beaino G, Khoshnood B, Kaminski M, et al. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective populationbased cohort study［J］. Dev Med Child Neurol, 2010, 52(6):e119-125.
［10］Munck P, Haataja L, Maunu J, et al. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006［J］. Acta Paediatr, 2010, 99(3):359-366.
［11］Fleming RE, Bacon BR. Orchestration of iron homeostasis［J］. N Engl J Med, 2005, 352(17):1741-1744.
［12］Muñoz Gómez M, Campos Garríguez A, García Erce JA, et al. Fisiopathology of iron metabolism: diagnostic and therapeutic implications［J］. Nefrologia, 2005, 25(1):9-19.
［13］Takeshima T, Johnston JM, Commissiong JW. Oligodendrocyte-type-2 astrocyte (O-2A) progenitors increase the survival of rat mesencephalic, dopaminergic neurons from death induced by serum deprivation［J］. Neurosci Lett, 1994, 166(2):178-182.
［14］Han F, Chen YX, Lu YM, et al. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells［J］. J Pineal Res, 2011, 51(1):1-12.
［15］Chen J, Cui X, Zacharek A, et al. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke［J］. Stroke, 2011, 42(2):445-452.
［16］Ganz T. Cellular iron: ferroportin is the only way out［J］. Cell Metab, 2005, 1(3):155-157.
［17］Burdo JR, Menzies SL, Simpson IA, et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat［J］. J Neurosci Res, 2001, 66(6):1198-1207.
［18］Qian ZM, Shen X. Brain iron transport and neurodegeneration［J］. Trends Mol Med, 2001, 7(3):103-108.
［19］Chen Y, Qian ZM, Du J, et al. Iron loading inhibits ferroportin1 expression in PC12 cells［J］. Neurochem Int, 2005, 47(7):507-513.
［20］Donovan A, Lima CA, Pinkus JL, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis［J］. Cell Metab, 2005, 1(3):191-200.
［21］Knutson MD, Oukka M, Koss LM, et al. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin［J］. Proc Natl Acad Sci U S A, 2005, 102(5):1324-1328.
［22］Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease［J］. Toxicology, 2011, 283(2-3):65-87.
［23］Takami T, Sakaida I. Iron regulation by hepatocytes and free radicals［J］. Clin Biochem Nutr, 2011, 48(2):103-106.
|
